Skip to content
2000
Volume 15, Issue 22
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

Despite a large number of neuroimaging studies in schizophrenia reporting subtle brain abnormalities, we do not know to what extent such abnormalities reflect the effects of antipsychotic treatment on brain structure. We therefore systematically reviewed cross-sectional and follow-up structural brain imaging studies of patients with schizophrenia treated with antipsychotics. 30 magnetic resonance imaging (MRI) studies were identified, 24 of them being longitudinal and six cross-sectional structural imaging studies. In patients with schizophrenia treated with antipsychotics, reduced gray matter volume was described, particularly in the frontal and temporal lobes. Structural neuroimaging studies indicate that treatment with typical as well as atypical antipsychotics may affect regional gray matter (GM) volume. In particular, typical antipsychotics led to increased gray matter volume of the basal ganglia, while atypical antipsychotics reversed this effect after switching. Atypical antipsychotics, however, seem to have no effect on basal ganglia structure.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/138161209788957456
2009-08-01
2025-04-22
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/138161209788957456
Loading

  • Article Type:
    Research Article
Keyword(s): antipsychotics; atypical neuroleptics; conventional; MRI; neuroimaging; Schizophrenia; typical
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test